Samco Small Cap Fund
The scheme seeks to generate long-term capital appreciation from a diversified portfolio predominantly consisting of equity and equity related instruments of small cap companies.
Growthvine rating: 1/5 — ranked #36 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹12.37 (as of 2026-10-01) |
|---|
| AUM | ₹196 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Umeshkumar Mehta |
|---|
| Exit load | 1% for redemption within 30 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −12.14% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 108.6% of NIFTY Smallcap 250's upside and — of its downside.
Market cap allocation
| Large cap | 0.0% |
|---|
| Mid cap | 6.1% |
|---|
| Small cap | 93.9% |
|---|
Concentration
| Top 5 holdings | 17.2% |
|---|
| Top 10 holdings | 31.8% |
|---|
| Total holdings | 76 |
|---|
| Index overlap | 18.1% |
|---|
| Active share | 81.9% |
|---|
Top holdings
- Clearing Corporation of India Ltd — 11.8%
- Ather Energy Limited — 4.0%
- Gland Pharma Limited — 3.4%
- Navin Fluorine International Limited — 3.3%
- Lalithaa Jewellery Mart Ltd — 3.3%
- Anand Rathi Wealth Limited — 3.2%
- Welspun Corp Limited — 3.2%
- Kirloskar Oil Engines Limited — 3.0%
- R R KABEL LIMITED — 3.0%
- Syrma SGS Technology Limited — 2.8%
Top sectors
- Derivatives — 17.0%
- Industrial Products — 16.7%
- Pharma & Biotech — 13.2%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 23.5% | Q1 (Top) | #3 of 34 |